Mia's Feed
Medical News & Research

2023 Report Shows 2,770 Cases of Arboviral Disease Across 48 States and D.C.

2023 Report Shows 2,770 Cases of Arboviral Disease Across 48 States and D.C.

Share this article

In 2023, nearly 2,800 arboviral disease cases were reported across most U.S. states, primarily caused by West Nile Virus, with serious health implications. Learn more about the latest CDC findings.

1 min read

In 2023, a total of 2,770 human cases of arboviral diseases were documented across 48 U.S. states and the District of Columbia, according to a report published in the June 12 issue of the Morbidity and Mortality Weekly Report by the CDC. The majority of these cases involved West Nile Virus (WNV), which constituted approximately 95% of the total, with 2,628 confirmed cases. These infections often led to hospitalizations, with 2,022 reported in total, and 208 deaths. Most cases (about 91%) began between July and September, aligning with peak mosquito activity season. Notably, three cases of WNV were linked to organ transplants from two donors, highlighting the importance of vigilance in transplant procedures. The second most common disease was Powassan virus, with 49 cases, showing an increase from the previous year’s record. Among children, La Crosse virus remained a significant cause of neuroinvasive arboviral disease. Health experts continue advising clinicians to consider arboviral testing in patients presenting with febrile or neurological symptoms, especially during tick and mosquito seasons, and among transplant or blood transfusion recipients.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Conflict in Congo Disrupts Medical Supply, Endangering Hundreds of Health Facilities

Conflict in eastern Congo has led to a critical shortage of essential medicines in over 200 health facilities, endangering thousands of lives amid ongoing violence and funding shortages.

New Hope for Rare Language Development Disorder: A Potential Therapeutic Breakthrough

A groundbreaking study from Heidelberg University Hospital uncovers a promising therapeutic target for FOXP1 syndrome, offering hope for treating language and developmental disorders through enzyme inhibition.

Global Study Shows Increased Longevity for People with Dementia

A groundbreaking global study reveals that people diagnosed with dementia are living longer than before, thanks to advancements in diagnosis and care strategies. The research highlights regional differences and emphasizes the importance of ongoing efforts to improve life expectancy for dementia patients.

Protein Biomarkers Linked to Chemotherapy Resistance in Bladder Cancer Uncovered

Scientists at Baylor College of Medicine have identified protein and molecular pathway patterns that can predict chemotherapy resistance in bladder cancer, offering new avenues for personalized treatment strategies.